ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed

Jian Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2063-8573; OpenAlex author ID A5101847466. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. Last author DOI 10.1016/j.intimp.2023.110505 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weimin Hu · 1 shared paper, 2023 · strength 0.19
- Paper The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic … DOI 10.1016/j.intimp.2023.110505 ↗
Kongfan Zhu · 1 shared paper, 2023 · strength 0.19
- Paper The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic … DOI 10.1016/j.intimp.2023.110505 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.